UC San Diego Prostate Cancer Patient Summit
|
On February 1, 2025, UC San Diego Health and Moores hosted the third iteration of this event that (1) united patients, caregivers, and medical experts to advance education, empowerment, and innovation in prostate cancer care, (2) featured keynote speaker and NFL legend John Elway, and (3) enabled attendees to learn the latest advancements in treatment, survivorship, and research. Learn More and View Photo Gallery>>
|
Healthy Stem Cells Become Oral Cancer
|
Research led by Moores Member and Associate Director of Basic Science J. Silvio Gutkind, PhD has revealed how healthy stem cells become cancer stem cells during the earliest stages of oral cancer. Learn More>>
|
Moores-Branded Zoom Backgrounds
|
Moores Member Receives 2025 Prebys Leadership Award
|
Moores Member Paula Aristizabal, MD is one of five recipients of this award that recognizes leaders who promote well-being for the residents of San Diego County. Congratulations to Dr. Aristizabal. Learn More>>
|
New Gene Therapy Offers Hope in the Fight Against Bladder Cancer
|
Doctors at UC San Diego are among the first in the United States to offer an FDA-approved gene therapy that may help bladder cancer patients avoid removal surgery. Moores Member Amirali Salmasi, MD, MS provides this therapy. Learn More>>
|
|
|
|
RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition
|
Xin Sun, PhD (Cancer Biology and Signaling)
|
|
|
| High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes
|
Rana R. McKay, MD (Solid Tumor Therapeutics)
|
|
|
|
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer
|
Silvio Gutkind, PhD (Cancer Biology and Signaling)
|
|
|
The Researcher Spotlight is designed to help you connect with fellow researchers, gain insights into their diverse projects, and discover the paths that led them to their current roles. Uncover a personal touch to their professional achievements, showcasing the varied perspectives within our cancer research community.
|
Jin Zhang, PhD, is a professor and vice chair in the Department of Pharmacology, as well as a professor in the Departments of Bioengineering and Chemistry & Biochemistry. Dr. Zhang’s laboratory is interested in understanding the molecular mechanisms and functional roles of signaling enzymes such as protein kinases and phosphatases.
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE)
|
The Science Of … Podcast, Episode 2, Season 2
|
This episode features Elena “Sofia” Cardenas Alcoser, PhD and students from high schools around the county. Through interacting with Dr. Sofia, a Postdoctoral Fellow in the Gutkind lab at Moores, the students learned what cell signaling is and how it functions in cancer.
|
SIREN 2025 National Research Meeting
|
COE, the Center for Health Equity, Education, and Research (CHEER), and the Promotores Advisory Board attended the third annual UCSF Social Interventions Research and Evaluation Network (SIREN) conference, “Advancing the Science of Social Care,” February 2–4, 2025 in San Diego. The conference convened social care researchers, practitioners, community members, advocates, and policymakers to understand healthcare sector investments in social care programs and policies. COE participated in a pre-conference workshop to share information and build community alongside three fellow SIREN grantees.
|
Post-Baccalaureates Join the Jackie Robinson Health Fair
|
Post-baccs Jessica Lang and Karina Garcia Ortiz joined COE liaisons at the first Jackie Robinson Health Fair of 2025 to interact with community partners and organizations to promote breast screenings, HIV testing, COVID and flu vaccination, and county resources. COE liaisons received community feedback and shared resources for residents on cancer prevention and support services.
|
|
|
|
